Display Settings:

Format

Send to:

Choose Destination

    Diabetes. 2008 Jul;57(7):1852-60. Epub 2008 Apr 8.

    Weak proinsulin peptide-major histocompatibility complexes are targeted in autoimmune diabetes in mice.

    Levisetti MG, Lewis DM, Suri A, Unanue ER.

    Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. mleviset@im.wustl.edu

    Comment in:

    OBJECTIVE: Weak major histocompatibility complex (MHC) binding of self-peptides has been proposed as a mechanism that may contribute to autoimmunity by allowing for escape of autoreactive T-cells from the thymus. We examined the relationship between the MHC-binding characteristics of a beta-cell antigen epitope and T-cell autoreactivity in a model of autoimmune diabetes. RESEARCH DESIGN AND METHODS: The binding of a proinsulin epitope, proinsulin-1(47-64) (PI-1[47-64]), to the MHC class II molecules I-A(g7) and I-A(k) was measured using purified class II molecules. T-cell reactivity to the proinsulin epitope was examined in I-A(g7+) and I-A(k+) mice. RESULTS: C-peptide epitopes bound very weakly to I-A(g7) molecules. However, C-peptide-reactive T-cells were induced after immunization in I-A(g7)-bearing mice (NOD and B6.g7) but not in I-A(k)-bearing mice (B10.BR and NOD.h4). T-cells reactive with the PI-1(47-64) peptide were found spontaneously in the peripancreatic lymph nodes of pre-diabetic NOD mice. These T-cells were activated by freshly isolated beta-cells in the presence of antigen-presenting cells and caused diabetes when transferred into NOD.scid mice. CONCLUSIONS: These data demonstrate an inverse relationship between self-peptide-MHC binding and T-cell autoreactivity for the PI-1(47-64) epitope in autoimmune diabetes.

    PMID: 18398138 [PubMed - indexed for MEDLINE]

    PMCID: 2453633

    Supplemental Content

    Click here to read Click here to read